• Mon, February 1, 2021

by: WOPRAI

Adam Jonas Downgraded (SPCE) to Hold and Increased Target to $600 on, Feb 1st, 2021

by: WOPRAI

Todd Fowler Upgraded (SNDR) to Buy and Held Target at $25 on, Feb 1st, 2021

by: WOPRAI

Stephen Ju Maintained (SNAP) at Buy with Increased Target to $59 on, Feb 1st, 2021

by: WOPRAI

Ian Macpherson Maintained (BKR) at Buy with Increased Target to $30 on, Feb 1st, 2021

by: WOPRAI

Hamir Patel Initiated (BLDP) at Hold and Held Target at $38 on, Feb 1st, 2021

by: WOPRAI

Courtney Yakavonis Maintained (CAT) at Sell with Increased Target to $158 on, Feb 1st, 2021

by: WOPRAI

Nicole Deblase Maintained (CAT) at Strong Buy with Increased Target to $233 on, Feb 1st, 2021

by: WOPRAI

Jamie Cook Maintained (CAT) at Buy with Increased Target to $235 on, Feb 1st, 2021

by: WOPRAI

Joel Tiss Maintained (CAT) at Hold with Increased Target to $190 on, Feb 1st, 2021

by: WOPRAI

Alexander Potter Maintained (TSLA) at Buy with Increased Target to $400 on, Feb 1st, 2021

by: WOPRAI

William Katz Maintained (TROW) at Hold with Decreased Target to $153 on, Feb 1st, 2021

by: WOPRAI

PJ Juvekar Maintained (CE) at Strong Buy with Decreased Target to $144 on, Feb 1st, 2021

by: WOPRAI

Benjamin Chaiken Maintained (VAC) at Buy with Increased Target to $199 on, Feb 1st, 2021

by: WOPRAI

William Wallace Maintained (UVSP) at Buy with Increased Target to $27 on, Feb 1st, 2021

by: WOPRAI

Andrew Fein Upgraded (UTHR) to Strong Buy and Increased Target to $195 on, Feb 1st, 2021

by: WOPRAI

John Eade Maintained (URI) at Strong Buy with Increased Target to $280 on, Feb 1st, 2021

by: WOPRAI

David Feaster Maintained (ABCB) at Strong Buy with Increased Target to $46 on, Feb 1st, 2021

by: WOPRAI

Betsy Graseck Maintained (SYF) at Buy with Increased Target to $53 on, Feb 1st, 2021

by: WOPRAI

Meng Jiao Maintained (SYF) at Strong Buy with Increased Target to $54 on, Feb 1st, 2021

by: WOPRAI

Markus Mittermaier Maintained (SWK) at Strong Buy with Increased Target to $241 on, Feb 1st, 2021

by: WOPRAI

Jason Helfstein Maintained (BIDU) at Buy with Increased Target to $305 on, Feb 1st, 2021

by: WOPRAI

Shawn Collins Maintained (BC) at Hold with Increased Target to $94 on, Feb 1st, 2021

by: WOPRAI

Gerrick Johnson Maintained (BC) at Hold with Increased Target to $95 on, Feb 1st, 2021

by: WOPRAI

Michael Lasser Downgraded (WSM) to Strong Sell and Held Target at $55 on, Feb 1st, 2021

by: WOPRAI

Nick Setyan Maintained (WING) at Buy with Increased Target to $175 on, Feb 1st, 2021

by: WOPRAI

Daniel Mckenzie Downgraded (AAL) to Hold on, Feb 1st, 2021

by: WOPRAI

Colin Bristow Initiated (BTAI) at Strong Buy and Held Target at $99 on, Feb 1st, 2021

by: WOPRAI

Ken Cacciatore Maintained (ARQT) at Buy with Increased Target to $80 on, Feb 1st, 2021

by: WOPRAI

David Feaster Maintained (AX) at Strong Buy with Increased Target to $48 on, Feb 1st, 2021

by: WOPRAI

Philip Cusick Upgraded (ATEX) to Hold and Increased Target to $40 on, Feb 1st, 2021

by: WOPRAI

Nathan Rice Maintained (ALGN) at Strong Buy with Increased Target to $625 on, Feb 1st, 2021

by: WOPRAI

C. Gregory Peters Maintained (AJG) at Strong Buy with Increased Target to $140 on, Feb 1st, 2021

by: WOPRAI

Brian Ossenbeck Maintained (UPS) at Hold and Held Target at $180 on, Feb 1st, 2021

by: WOPRAI

William Wallace Upgraded (UBSI) to Buy and Held Target at $36 on, Feb 1st, 2021

by: WOPRAI

Scott Graham Maintained (AOS) at Strong Buy with Increased Target to $72 on, Feb 1st, 2021

by: WOPRAI

Yoni Yadgaran Maintained (ANGI) at Buy with Increased Target to $18 on, Feb 1st, 2021

by: WOPRAI

Jason Helfstein Maintained (AMZN) at Buy on, Feb 1st, 2021

by: WOPRAI

Ami Fadia Maintained (AMRN) at Buy with Increased Target to $16 on, Feb 1st, 2021

by: WOPRAI

Rick Patel Maintained (TPR) at Strong Buy with Increased Target to $37 on, Feb 1st, 2021

by: WOPRAI

Tycho Peterson Maintained (TMO) at Buy with Increased Target to $560 on, Feb 1st, 2021

by: WOPRAI

Mark May Maintained (YELP) at Hold with Increased Target to $33 on, Feb 1st, 2021

by: WOPRAI

James Faucette Initiated (AXON) at Buy and Held Target at $185 on, Feb 1st, 2021

by: WOPRAI

Michael Phillips Maintained (AXS) at Hold with Decreased Target to $53 on, Feb 1st, 2021

by: WOPRAI

Michael Pachter Maintained (U) at Buy with Increased Target to $175 on, Feb 1st, 2021

by: WOPRAI

Stephen Ju Maintained (TTWO) at Hold with Increased Target to $199 on, Feb 1st, 2021

by: WOPRAI

Gerry Sweeney Maintained (TTEK) at Strong Buy with Increased Target to $27 on, Feb 1st, 2021

  • Tue, February 2, 2021

by: WOPRAI

Brian Abrahams Maintained (VRTX) at Buy and Held Target at $264 on, Feb 2nd, 2021

by: WOPRAI

Ben Davis Downgraded (BHP) to Strong Sell on, Feb 2nd, 2021

Ken Cacciatore Maintained (ARQT) at Buy with Increased Target to $80 on, Feb 1st, 2021

Ken Cacciatore of Cowen & Co., Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Buy with Increased Target from $55 to $80 on, Feb 1st, 2021.

Ken has made no other calls on ARQT in the last 4 months.



There are 2 other peers that have a rating on ARQT. Out of the 2 peers that are also analyzing ARQT, 0 agree with Ken's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Ken

  • Graig Suvannavejh of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $36 on, Monday, November 9th, 2020
  • Gregg Gilbert of "Truist Securities" Initiated at Strong Buy and Held Target at $38 on, Thursday, October 8th, 2020

Like: 👍